Mirae Asset Global ETFs Holdings
ORKA

Mirae Asset Global ETFs Holdings’s Oruka Therapeutics ORKA Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio ORKA Stock Details ORKA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.67M Buy
28,204
+7,240
+35% +$482K ﹤0.01% 1110
2026
Q1 		$1.02M Buy
20,964
+812
+4% +$28.2K ﹤0.01% 1518
2025
Q4 		$608K Buy
20,152
+7,009
+53% +$195K ﹤0.01% 1790
2025
Q3 		$253K Sell
13,143
-1,749
-12% -$25.9K ﹤0.01% 2201
2025
Q2 		$167K Buy
+14,892
New +$155K ﹤0.01% 2373

Other funds holding ORKA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's ORKA Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings increased its Oruka Therapeutics (ORKA) stake by 35% in Q2 2026, buying an estimated $482K and bringing the position to 28,204 shares worth $2.67M. The position accounts for ﹤0.01% of the portfolio, ranked #1110.

Mirae Asset Global ETFs Holdings first reported a position in ORKA in Q2 2025 and has held it in 5 quarters since. 255 funds tracked by Wall St. Rank hold ORKA as of Q2 2026.

  • Mirae Asset Global ETFs Holdings held 28,204 shares of Oruka Therapeutics worth $2.67M as of Q2 2026.
  • Mirae Asset Global ETFs Holdings bought 7,240 Oruka Therapeutics shares in Q2 2026, an estimated $482K.
  • Oruka Therapeutics made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #1110 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in Oruka Therapeutics in Q2 2025 and has held it in 5 quarters since.
  • 255 funds tracked by Wall St. Rank held Oruka Therapeutics as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.